MS patients stay stable after switching to At-Home injections
NCT ID NCT04486716
First seen Jan 20, 2026 · Last updated May 20, 2026 · Updated 18 times
Summary
This study looked at 111 adults with relapsing multiple sclerosis who switched from an IV anti-CD20 medication to a self-injected drug called ofatumumab. The goal was to see if the new treatment could keep their disease under control. After 12 months, most participants had no new or worsening brain lesions, suggesting the switch is a safe and effective option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AMO Corporation
Tallahassee, Florida, 32312, United States
-
Alabama Neurology Associates PC
Birmingham, Alabama, 35209, United States
-
Beth Israel Deaconess Medical Cente
Boston, Massachusetts, 02215, United States
-
Caribbean Center for Clinical Research, Inc
Guaynabo, 00968, Puerto Rico
-
Central TX Neuro Consultants P A
Round Rock, Texas, 78681, United States
-
Cleveland Clinic Foundation
Las Vegas, Nevada, 89106, United States
-
Columbus Neuroscience
Westerville, Ohio, 43082, United States
-
Ctr for Neurology and Spine
Phoenix, Arizona, 85018, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Dragonfly Research LLC
Wellesley, Massachusetts, 02481, United States
-
Infinity Clinical Research LLC
Hollywood, Florida, 33024, United States
-
International Neurorehab Institute
Lutherville, Maryland, 21093, United States
-
Ms Ctr Of Northeastern Ny
Latham, New York, 12110, United States
-
Neuro Center
Pomona, California, 91767, United States
-
Neurology Center of New England PC
Foxborough, Massachusetts, 02035, United States
-
Parkland Health and Hospital Systems
Dallas, Texas, 75325, United States
-
Sibyl Wray MD Neurology PC
Knoxville, Tennessee, 37922, United States
-
Swedish Neuroscience Institute
Seattle, Washington, 98122, United States
-
UC Health Neuroscience Ctr
Aurora, Colorado, 80045, United States
-
University Of South Florida
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.